IMPACT OF UMECLIDINIUM/VILANTEROL (UMEC/VI) VS TIOTROPIUM (TIO), FLUTICASONE PROPIONATE/SALMETEROL (FP/SAL), AND BUDESONIDE/FORMOTEROL (B/F) ON TIME-TO-FIRST SEVERE EXACERBATION AMONG PATIENTS WITH COPD WITH HIGH COMORBIDITIES AND HIGH COSTS

Authors :: Qin Shen
Riju Ray
Sean D. MacKnight
Guillaume Germain
François Laliberté
Mei Sheng Duh
David Slade
Chad Moretz
Beth Hahn
Source :: Chest. 158:A1718-A1719
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Pulmonary and Respiratory Medicine
medicine.medical_specialty
COPD
business.industry
Severe exacerbation
Fluticasone Propionate Salmeterol
Critical Care and Intensive Care Medicine
medicine.disease
Gastroenterology
Budesonide/formoterol
UMECLIDINIUM/VILANTEROL
Internal medicine
medicine
Cardiology and Cardiovascular Medicine
business
medicine.drug

Full Text Access

Tools